{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:35:23Z","timestamp":1793381723049,"version":"4.5.0"},"update-to":[{"DOI":"10.12688\/openreseurope.19988.1","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000}}],"reference-count":69,"publisher":"CERN","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Commission","award":["956154"],"award-info":[{"award-number":["956154"]}],"id":[{"id":"https:\/\/ror.org\/00k4n6c32","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Open Res Europe"],"abstract":"<jats:p>Background\n                    Innovative antibiotic discovery strategies are urgently needed to successfully combat infections caused by multi-drug-resistant bacteria.\n                \n                \n                    Methods\n                    We employed a direct screening approach to identify compounds with antimicrobial and antimicrobial helper-drug activity against Gram-positive and Gram-negative bacteria. We used this platform in two different strains of methicillin-resistant \n                        Staphylococcus aureus (MRSA) and aminoglycoside-resistant strains of \n                        Escherichia coli to screen for antimicrobials compounds, which potentiate the activity of aminoglycoside antibiotics. Screening was performed with 75 known microbial products and 880 extracts from \n                        Actinomycetes from a collection at the company Naicons.\n                \n                \n                    Results\n                    The antibiotics rifamycin O and thermorubin inhibited the growth of neomycin-resistant \n                        E. coli in combination with 1\/8 MIC of neomycin, suggesting a potential application as adjuvant drugs for neomycin. Additionally, in the \n                        Actinomycetes extract screen, one extract with antimicrobial activity and one extract with gentamicin adjuvant activity against gentamicin-resistant \n                        E. coli were identified, demonstrating the applicability of the screening approach. Against MRSA, the paramagnetoquinones, the lantibiotic NAI-107 and the spirotetronate NAI-414 showed the most pronounced antimicrobial activity. Difference is susceptibility towards antimicrobials and extracts were observed between the two MRSA strains used for screening.\n                \n                \n                    Conclusion\n                    Compounds with antibacterial and helper drug activity were identified using our screening approach. The results demonstrate the importance of strain selection in antimicrobial screening and highlight the potential of natural products as a source of potential new antibacterial and adjuvant therapies against both Gram-positive and Gram-negative bacteria.<\/jats:p>","DOI":"10.12688\/openreseurope.19988.2","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T13:25:05Z","timestamp":1754918705000},"update-policy":"https:\/\/doi.org\/10.68336\/openreseurope.updatepolicy","source":"Crossref","is-referenced-by-count":4,"title":["Screening \n                    Actinomycetes extracts for antimicrobial compounds against methicillin-resistant \n                    Staphylococcus aureus and helper-compounds against\n                     aminoglycoside-resistant\n                     E. coli"],"prefix":"10.68336","author":[{"given":"Dina Al","family":"Nahhas","sequence":"first","affiliation":[{"name":"Porto Conte Ricerche, Alghero, 07041, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Marina","family":"Wellner","sequence":"additional","affiliation":[{"name":"Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg, 1870, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Sosio","sequence":"additional","affiliation":[{"name":"Naicons, Milano, 20139, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia I","family":"Maffioli","sequence":"additional","affiliation":[{"name":"Naicons, Milano, 20139, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Pisanu","sequence":"additional","affiliation":[{"name":"Porto Conte Ricerche, Alghero, 07041, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Uzzau","sequence":"additional","affiliation":[{"name":"Biomedical Sciences, University of Sassari, Sassari, 07100, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Pagnozzi","sequence":"additional","affiliation":[{"name":"Porto Conte Ricerche, Alghero, 07041, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2121-8979","authenticated-orcid":true,"given":"Stefano","family":"Donadio","sequence":"additional","affiliation":[{"name":"Naicons, Milano, 20139, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6225-6587","authenticated-orcid":true,"given":"John Elmerdahl","family":"Olsen","sequence":"additional","affiliation":[{"name":"Veterinary and Animal Sciences, University of Copenhagen, Frederiksberg, 1870, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"13904","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"78009","unstructured":"1. European Union: A European one health action plan against Antimicrobial Resistance (AMR) contents. 2017. Reference Source (https:\/\/health.ec.europa.eu\/system\/files\/2020-01\/amr_2017_action-plan_0.pdf)"},{"key":"78010","unstructured":"2. World Health Organization: (WHO):: Global action plan on antimicrobial resistance. ISBN 9789241509763,2015. Reference Source (https:\/\/iris.who.int\/bitstream\/handle\/10665\/193736\/9789241509763_eng.pdf?sequence=1&isAllowed=y)"},{"key":"78011","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3975"},{"key":"78012","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02724-0"},{"key":"78013","unstructured":"5. World Health Organization: WHO publishes list of bacteria for which new antibiotics are urgently needed. (Accessed Last: 19.7.2023). Reference Source (https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed)"},{"key":"78014","unstructured":"6. World Health Organization: WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control Antimicrobial Resistance. 2024. Reference Source (https:\/\/www.google.co.in\/books\/edition\/WHO_bacterial_priority_pathogens_list_20\/UjAJEQAAQBAJ?hl=en&gbpv=1&printsec=frontcover)"},{"key":"78015","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2017.08.027"},{"key":"78016","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a030239"},{"key":"78017","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.67.4.593-656.2003"},{"key":"78018","doi-asserted-by":"publisher","DOI":"10.1021\/acs.accounts.0c00895"},{"key":"78019","doi-asserted-by":"publisher","DOI":"10.1021\/cr0301088"},{"key":"78020","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a027029"},{"key":"78021","doi-asserted-by":"publisher","DOI":"10.1128\/ecosalplus.ESP-0002-2018"},{"key":"78022","unstructured":"14. Chaves BJ, Tadi P: Gentamicin. StatPearls Publishing, Treasure Island (FL),2020. https:\/\/pubmed.ncbi.nlm.nih.gov\/32491482"},{"key":"78023","doi-asserted-by":"publisher","DOI":"10.1186\/s40813-022-00283-w"},{"key":"78024","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1230"},{"key":"78025","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.6.2.231"},{"key":"78026","doi-asserted-by":"publisher","DOI":"10.1016\/j.surge.2012.05.003"},{"key":"78027","doi-asserted-by":"publisher","DOI":"10.1111\/j.1462-5822.2012.01832.x"},{"key":"78028","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61999-1"},{"key":"78029","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0710217105"},{"key":"78030","doi-asserted-by":"publisher","DOI":"10.3201\/eid1512.090378"},{"key":"78031","doi-asserted-by":"publisher","DOI":"10.1016\/bs.mie.2021.11.005"},{"key":"78032","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2014.11.012"},{"key":"78033","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.01143-13"},{"key":"78034","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-55-14461"},{"key":"78035","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2201"},{"key":"78036","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00019-15"},{"key":"78037","unstructured":"29. NAICONS Naicons Laboratories. (accessed on 6 January 2024). Reference Source (https:\/\/naicons.com\/)"},{"key":"78038","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-54169-8"},{"key":"78039","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5331.1453"},{"key":"78040","unstructured":"32. Patel, Cockerill, Bradford: M100\u2013S25 Performance standards for antimicrobial susceptibility testing; twenty-fifth informational supplement an informational supplement for global application developed through the clinical and laboratory standards institute consensus process. Berwyn, PA USA,2015."},{"key":"78041","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.2c00958"},{"key":"78042","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2012.92"},{"key":"78043","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab941"},{"key":"78044","doi-asserted-by":"publisher","DOI":"10.1007\/978-90-481-3834-0_6"},{"key":"78045","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-020-00478-9"},{"key":"78046","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.70780"},{"key":"78047","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1055929"},{"key":"78048","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jnatprod.4c00857"},{"key":"78049","unstructured":"41. NAICONS Micro4all."},{"key":"78050","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2007.05.011"},{"key":"78051","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05515-6"},{"key":"78052","doi-asserted-by":"publisher","DOI":"10.5937\/savteh1601005I"},{"key":"78053","unstructured":"45. EUCAST The European Committee on Antimicrobial Susceptibility Testing: Breakpoint Tables for Interpretation of MICs and Zone Diameters. (accessed on 26 February 2024). Reference Source (http:\/\/www.eucast.org)"},{"key":"78054","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2333"},{"key":"78055","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-49-13515"},{"key":"78056","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237948"},{"key":"78057","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2016.06.009"},{"key":"78058","doi-asserted-by":"publisher","DOI":"10.1021\/jm970791o"},{"key":"78059","doi-asserted-by":"publisher","DOI":"10.1021\/cr030112j"},{"key":"78060","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36528-7"},{"key":"78061","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.38.1752"},{"key":"78062","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10050483"},{"key":"78063","doi-asserted-by":"publisher","DOI":"10.1111\/1751-7915.12123"},{"key":"78064","doi-asserted-by":"publisher","DOI":"10.1093\/jimb\/kuab017"},{"key":"78065","doi-asserted-by":"publisher","DOI":"10.1007\/s10295-015-1723-5"},{"key":"78066","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2019.10.008"},{"key":"78067","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jnatprod.6b00654"},{"key":"78068","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.537449"},{"key":"78069","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jnatprod.8b00354"},{"key":"78070","doi-asserted-by":"publisher","DOI":"10.1021\/np300003n"},{"key":"78071","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24213840"},{"key":"78072","doi-asserted-by":"publisher","DOI":"10.1016\/S0302-4598(01)00102-7"},{"key":"78073","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2021.128334"},{"key":"78074","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(85)90062-2"},{"key":"78075","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90612-7"},{"key":"78076","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.72185"},{"key":"78077","doi-asserted-by":"crossref","unstructured":"69. Al Nahhas D, Wellner SM, Sosio M, et al.: Screening actinomycetes extracts for antimicrobial compounds against methicillin-resistant Staphylococcus aureus and helper-compounds against aminoglycoside-resistant E. Coli. (accessed on 26 March 2025). https:\/\/osf.io\/sq6gz\/","DOI":"10.12688\/openreseurope.19988.2"}],"container-title":["Open Research Europe"],"original-title":[],"link":[{"URL":"https:\/\/open-research-europe.ec.europa.eu\/articles\/5-110\/v2\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ore.eu\/ore\/article\/download\/908\/version\/1573\/3143","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ore.eu\/ore\/article\/download\/908\/version\/1573\/3144","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ore.eu\/ore\/article\/download\/908\/version\/1573\/3143","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:12:11Z","timestamp":1793380331000},"score":1,"resource":{"primary":{"URL":"https:\/\/ore.eu\/ore\/article\/view\/908\/version\/1573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":69,"URL":"https:\/\/doi.org\/10.12688\/openreseurope.19988.2","relation":{"is-version-of":[{"id-type":"doi","id":"10.12688\/openreseurope.19988.1","asserted-by":"subject"}],"has-review":[{"id-type":"doi","id":"10.21956\/openreseurope.22663.r58980","asserted-by":"object"},{"id-type":"doi","id":"10.21956\/openreseurope.22663.r58056","asserted-by":"object"},{"id-type":"doi","id":"10.21956\/openreseurope.22663.r58057","asserted-by":"object"}]},"ISSN":["2732-5121"],"issn-type":[{"value":"2732-5121","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"2025-08-11","name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"This project has received funding from the European Union\u2019s Horizon 2020 research and innovation program under the grant agreement number 956154(Marie Sklodowska-Curie).","name":"funding_statement","label":"Funding Statement","group":{"name":"funding_information","label":"Funding Information"}}],"article-number":"110"}}